Skip to main content
. 2009 Oct 19;54(1):109–115. doi: 10.1128/AAC.01041-09

FIG. 1.

FIG. 1.

Distribution of resistance to fluoroquinolones (ciprofloxacin, levofloxacin, ofloxacin, moxifloxacin, or gatifloxacin), piperacillin or piperacillin-tazobactam, carbapenems (imipenem or meropenem), or extended-spectrum cephalosporins (ceftriaxone, ceftazidime, cefotaxime, or cefepime).